Drugs / BUCCALIN®
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT06736288 Comparator | Oct 2025 → Apr 2027 expected | lower respiratory tract disorder, respiratory tract infectious disorder | Laboratorio Farmaceutico SIT srl | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BUCCALIN | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06736288 ↗ |
| Route | Oral | “should be taken in the morning on an empty stomach” NCT06736288 ↗ |